Non-small cell lung cancer continues to remain one of the main reasons behind cancer related deaths all across the world. Continuous studies and research works are going on that could help in…
Tag: Lung Cancer
SABR For Inoperable Early Stage NSCLC
Stereotactic Ablative Radiotherapy (SABR) is an external beam treatment modality that delivers high precision large doses of radiation. In simple words, it is a way of giving Radiotherapy to precisely target cancer…
Combination Of Radiation And Immunotherapy For Advanced Non-Small Cell Lung Cancer
According to the new study by researchers from the UCLA Health Jonsson Comprehensive Cancer Center, using high doses of radiation with an ablative radiotherapy technique is effective for treatment with locally advanced…
Inhalable Sensors Created By MIT Engineers To Detect Lung Cancer Early
The engineers from the Massachusetts Institute of Technology (MIT) have come up with a diagnostic system to make screening of lung cancer more accessible on a global level. Low-dose computed tomography can…
Research Suggests that a type of allergy medicine might help with lung cancer Treatment
The researchers at the Icahn School of Medicine at Mount Sinai have found an allergy pathway that, when blocked, could unlease anti-tumor immunity in mouse models of NSCLC (non-small cell lung cancer)….
FDA Places Hold on Iovance’s Lung Cancer Treatment Trial
Lung cancer is one of the most deadly diseases all around the world. Various companies are during clinical trials to offer better and effective treatment options for those suffering from lung cancer….
Study Suggests Small Amounts Of Physical Activity Can Be Beneficial In Lung Cancer
Lung cancer continues to affects more individuals each passing year. According to a new study led by Curtin University, people with incurable forms of lung cancer may survive longer if they engage…
Dizal Published New Pivotal Phase II Trial Data on Sunvozertinib in NSCLC
Shanghai-based biopharmaceutical company, Dizal, has published new Pivotal Phase II Trial Data on sunvozertinib in non-small cell lung cancer (NSCLC). Sunvozertinib is an oral and selective tyrosine kinase inhibitor that has a…